• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助化疗后原发肿瘤和淋巴结状态的病理反应预测价值比较在局部进展期胃癌中的应用。

Comparison of the predictive value of pathological response at primary tumor and lymph node status after neoadjuvant chemotherapy in locally advanced gastric cancer.

机构信息

Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.

Graduate School, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100005, China.

出版信息

Clin Transl Oncol. 2023 Aug;25(8):2462-2471. doi: 10.1007/s12094-023-03130-8. Epub 2023 Apr 24.

DOI:10.1007/s12094-023-03130-8
PMID:37093455
Abstract

BACKGROUND

Preoperative chemotherapy has been increasingly used in locally advanced gastric cancer (LAGC). However, the prognostic factors are still insufficient. This study aimed to investigate the prognostic significance of pathological response of the primary tumor to neoadjuvant chemotherapy (NACT) and the lymph node status after NACT.

METHODS

Data from 160 patients with LAGC treated with NACT followed by gastrectomy and met the inclusion criteria between March 2016 and December 2019 were retrospectively reviewed. Pathological evaluation after NACT was based on the grade of pathological response of the primary tumor and the status of lymph node. Survival curves for overall survival (OS) and disease-free survival (DFS) were estimated using the Kaplan-Meier method, and the log-rank test was used to compare survival difference. Univariate and multivariate analyses for prognostic factors were based on the Cox regression.

RESULTS

Among 160 selected cases, 90 had pathological response (PR), while 70 had no pathological response (nPR) to NACT. Smaller tumor size was presented in PR group, which also had lower level of signet ring cell features, compared to nPR group (all p < 0.05). Based on the status of lymph nodes, nodal status (-) group showed smaller tumor size, lower depth of tumor invasion, better differentiated degree, lower level of signet ring cell features, lower rate of lymphatic and venous invasion and less advanced ypTNM stage (all p < 0.05). Survival was equivalent between PR and nPR group (all p > 0.05), while patients with no lymph node metastasis had better DFS than that with lymph node metastasis (HR 0.301, 95% CI 0.194-0.468, p = 0.002). Multivariable Cox regression analysis identified that lymph node status after NACT was an independent prognostic factor associated with survival (OS: hazard ratio 1.756, 95% CI 1.114-3.278, p = 0.029; DFS: hazard ratio 1.901, 95% CI 1.331-3.093, p = 0.012).

CONCLUSION

Lymph node status is a potential independent prognostic factor for LAGC patients treated with NACT and may be more efficient than pathological response in primary tumor.

摘要

背景

术前化疗已越来越多地用于局部晚期胃癌(LAGC)。然而,预后因素仍然不足。本研究旨在探讨新辅助化疗(NACT)后原发肿瘤病理反应和 NACT 后淋巴结状态的预后意义。

方法

回顾性分析了 2016 年 3 月至 2019 年 12 月期间接受 NACT 后胃切除术且符合纳入标准的 160 例 LAGC 患者的数据。NACT 后病理评估基于原发肿瘤病理反应程度和淋巴结状态。使用 Kaplan-Meier 法估计总生存期(OS)和无病生存期(DFS)的生存曲线,并使用对数秩检验比较生存差异。单因素和多因素预后因素分析基于 Cox 回归。

结果

在 160 例入选病例中,90 例对 NACT 有病理反应(PR),70 例无病理反应(nPR)。PR 组肿瘤较小,与 nPR 组相比,印戒细胞特征水平较低(均 p<0.05)。根据淋巴结状态,淋巴结(-)组肿瘤较小,肿瘤浸润深度较浅,分化程度较好,印戒细胞特征水平较低,淋巴管和静脉侵犯率较低,ypTNM 分期较晚(均 p<0.05)。PR 组和 nPR 组的生存相当(均 p>0.05),而无淋巴结转移的患者的 DFS 优于有淋巴结转移的患者(HR 0.301,95%CI 0.194-0.468,p=0.002)。多因素 Cox 回归分析确定 NACT 后淋巴结状态是与生存相关的独立预后因素(OS:风险比 1.756,95%CI 1.114-3.278,p=0.029;DFS:风险比 1.901,95%CI 1.331-3.093,p=0.012)。

结论

淋巴结状态是接受 NACT 治疗的 LAGC 患者的潜在独立预后因素,其在原发肿瘤中的效率可能高于病理反应。

相似文献

1
Comparison of the predictive value of pathological response at primary tumor and lymph node status after neoadjuvant chemotherapy in locally advanced gastric cancer.新辅助化疗后原发肿瘤和淋巴结状态的病理反应预测价值比较在局部进展期胃癌中的应用。
Clin Transl Oncol. 2023 Aug;25(8):2462-2471. doi: 10.1007/s12094-023-03130-8. Epub 2023 Apr 24.
2
Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy.淋巴结比率是新辅助化疗后局部进展期胃癌患者的前瞻性预后指标。
World J Surg Oncol. 2022 Aug 17;20(1):261. doi: 10.1186/s12957-022-02725-9.
3
The largest lymph node defined response to neoadjuvant chemotherapy can predict long-term prognosis in locally advanced gastric cancer.新辅助化疗后最大淋巴结反应可预测局部进展期胃癌的长期预后。
Abdom Radiol (NY). 2023 Dec;48(12):3653-3660. doi: 10.1007/s00261-023-04048-z. Epub 2023 Sep 27.
4
[Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].[预后营养指数在进展期胃癌患者中的临床意义]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):180-184.
5
Tumor regression grade combined with post-therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma.肿瘤退缩分级联合治疗后淋巴结状态:新辅助治疗联合手术治疗局部进展期胃食管结合部及胃癌患者的一种新的独立预后因素。
Cancer Med. 2023 Oct;12(19):19633-19643. doi: 10.1002/cam4.6597. Epub 2023 Sep 25.
6
[Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].[淋巴管浸润对Ⅰ期胃癌患者根治性胃切除术后预后的影响]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):175-179.
7
Lymph node regression after neoadjuvant chemotherapy: A predictor of survival in gastric cancer.新辅助化疗后淋巴结退缩:胃癌生存的预测因素。
J Surg Oncol. 2020 Apr;121(5):795-803. doi: 10.1002/jso.25785. Epub 2019 Nov 26.
8
Predictors of Lymph Node Metastasis and Differences Between Pure and Mixed Histologic Types of Early Gastric Signet-ring Cell Carcinomas.早期胃印戒细胞癌的纯和混合组织学类型之间的淋巴结转移预测因子及差异。
Am J Surg Pathol. 2020 Jul;44(7):934-942. doi: 10.1097/PAS.0000000000001460.
9
[Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].奥沙利铂联合S-1辅助化疗用于D2淋巴结清扫术后局部进展期胃癌患者的安全性和疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Feb 25;24(2):145-152. doi: 10.3760/cma.j.cn.441530-20201016-00561.
10
Lymph node ratio is a prognostic indicator for locally advanced gastric cancer after neoadjuvant immunochemotherapy.淋巴结比率是新辅助免疫化疗后局部进展期胃癌的预后指标。
BMC Gastroenterol. 2024 Oct 19;24(1):371. doi: 10.1186/s12876-024-03462-x.

引用本文的文献

1
Stacking classifiers based on integrated machine learning model: fusion of CT radiomics and clinical biomarkers to predict lymph node metastasis in locally advanced gastric cancer patients after neoadjuvant chemotherapy.基于集成机器学习模型的堆叠分类器:融合CT影像组学和临床生物标志物以预测局部晚期胃癌患者新辅助化疗后的淋巴结转移
BMC Cancer. 2025 May 6;25(1):834. doi: 10.1186/s12885-025-14259-w.
2
Systemic immunoinflammatory index and prognostic nutrition index for predicting pathologic responses of patients with advanced gastric cancer after neoadjuvant therapy for advanced gastric cancer.全身免疫炎症指数和预后营养指数对晚期胃癌新辅助治疗后患者病理反应的预测作用
Am J Cancer Res. 2024 Aug 25;14(8):3922-3934. doi: 10.62347/PAYM2267. eCollection 2024.
3
Cytoreduction and Hyperthermic Intraperitoneal Paclitaxel and Cisplatin for Gastric Cancer with Peritoneal Metastasis.腹腔热灌注紫杉醇和顺铂联合细胞减灭术治疗胃癌合并腹膜转移
Ann Surg Oncol. 2024 Jan;31(1):622-629. doi: 10.1245/s10434-023-14379-2. Epub 2023 Oct 26.